Frontiers in Allergy (Jul 2023)
EUFOREA summit in Brussels 2023: inspiring the future of allergy & respiratory care
- P. W. Hellings,
- P. W. Hellings,
- S. Lau,
- G. K. Scadding,
- G. K. Scadding,
- L. Bjermer,
- V. Backer,
- A. M. Chaker,
- D. M. Conti,
- E. De Corso,
- Z. Diamant,
- Z. Diamant,
- Z. Diamant,
- Z. Diamant,
- R. Djukanovic,
- W. Fokkens,
- P. Gevaert,
- C. L. Gray,
- C. L. Gray,
- J. K. Han,
- L. G. Heaney,
- H. J. Hoffmann,
- M. Jesenak,
- P. Johansen,
- P. Johansen,
- M. S. Kumaran,
- M. McDonald,
- E. Melén,
- J. Mullol,
- S. Reitsma,
- D. Ryan,
- D. Ryan,
- G. Scadding,
- P. Schmid-Grendelmeier,
- P. Schmid-Grendelmeier,
- T. Teeling,
- M. Odemyr,
- U. Wahn
Affiliations
- P. W. Hellings
- Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals, Leuven, Belgium
- P. W. Hellings
- Upper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium
- S. Lau
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitaetsmedizin, Berlin, Germany
- G. K. Scadding
- Department of Allergy & Rhinology, Royal National ENT Hospital, London, United Kingdom
- G. K. Scadding
- Division of Immunity and Infection, University College, London, United Kingdom
- L. Bjermer
- Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden
- V. Backer
- Department of Otorhinolaryngology, Head & Neck Surgery, and Audiology, Rigshospitalet, Copenhagen University, Copenhagen, Denmark
- A. M. Chaker
- Department of Otorhinolaryngology and Center for Allergy and Environment (ZAUM), TUM School of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
- D. M. Conti
- The European Forum for Research and Education in Allergy and Airway Diseases Scientific Expert Team Members, Brussels, Belgium
- E. De Corso
- 0Otolaryngology Head and Neck Surgery, A. Gemelli University Hospital Foundation IRCCS, Rome, Italy
- Z. Diamant
- Department of Respiratory Medicine & Allergology, Institute for Clinical Science, Skane University Hospital, Lund University, Lund, Sweden
- Z. Diamant
- 1Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic
- Z. Diamant
- 2Department Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
- Z. Diamant
- 3Dept of Microbiology Immunology & Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium
- R. Djukanovic
- 4NIHR Southampton Biomedical Research Centre, Faculty of Medicine, University of Southampton, Southampton, United Kingdom
- W. Fokkens
- 5Department of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, Netherlands.
- P. Gevaert
- Upper Airways Research Laboratory, Department of Head and Skin, Ghent University, Ghent, Belgium
- C. L. Gray
- 6Division of Allergy, Department of Paediatrics and Child Health, University of Cape Town, Rondebosch, South Africa
- C. L. Gray
- 7Specialist Allergist, Kidsallergy Centre, Cape Town, South Africa
- J. K. Han
- 8Department of Otolaryngology & Head and Neck Surgery, Eastern Virginia Medical School, Norfolk, VA, United States
- L. G. Heaney
- 9Wellcome-Wolfson Institute for Experimental Medicine, Queens University Belfast, Belfast, United Kingdom
- H. J. Hoffmann
- 0Department of Clinical Medicine, University of Aarhus, Aarhus, Denmark
- M. Jesenak
- 1Department of Pulmonology and Phthisiology, Department of Pediatrics, Department of Clinical Immunology and Allergology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Hospital in Martin, Martin, Slovakia
- P. Johansen
- 2Department of Dermatology, University of Zurich, Zurich, Switzerland
- P. Johansen
- 3Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
- M. S. Kumaran
- 4Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
- M. McDonald
- 5Mediclinic Sandton, Johannesburg, South Africa
- E. Melén
- 6Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet and Sachs’ Children and Youth Hospital, Stockholm, Sweden
- J. Mullol
- 7Rhinology Unit and Smell Clinic, ENT Department, Hospital Clínic, FRCB-IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia, Spain
- S. Reitsma
- 5Department of Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, Netherlands.
- D. Ryan
- 8Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom
- D. Ryan
- 9International Primary Care Respiratory Group., Edinburgh, United Kingdom
- G. Scadding
- 0Allergy, Royal Brompton Hospital, London, United Kingdom
- P. Schmid-Grendelmeier
- 3Allergy Unit, Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
- P. Schmid-Grendelmeier
- 1Christine-Kühne Center for Allergy research and Education CK-CARE, Davos, Switzerland
- T. Teeling
- 2Patient Advisory Board of the European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium
- M. Odemyr
- 2Patient Advisory Board of the European Forum for Research and Education in Allergy and Airway Diseases, Brussels, Belgium
- U. Wahn
- Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitaetsmedizin, Berlin, Germany
- DOI
- https://doi.org/10.3389/falgy.2023.1236977
- Journal volume & issue
-
Vol. 4
Abstract
In March 2023, the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA) organized its bi-annual Summit in Brussels with expert panel members of EUFOREA, representatives of the EUFOREA patient advisory board, and the EUFOREA board and management teams. Its aim was to define the research, educational and advocacy initiatives to be developed by EUFOREA over the next 2 years until the 10th anniversary in 2025. EUFOREA is an international non-for-profit organization forming an alliance of all stakeholders dedicated to reducing the prevalence and burden of chronic allergic and respiratory diseases via research, education, and advocacy. Based on its medical scientific core competency, EUFOREA offers an evidence-supported platform to introduce innovation and education in healthcare leading to optimal patient care, bridging the gap between latest scientific evidence and daily practice. Aligned with the mission of improving health care, the expert panels of asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS) & European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS), allergen immunotherapy (AIT) and paediatrics have proposed and elaborated a variety of activities that correspond to major unmet needs in the allergy and respiratory field. The current report provides a concise overview of the achievements, ambitions, and action plan of EUFOREA for the future, allowing all stakeholders in the allergy and respiratory field to be up-dated and inspired to join forces in Europe and beyond.
Keywords
